Lakefront Biotherapeutics
The Director Transactions role supports the Chief Business Officer and Vice President of Transactions in executing business development activities, including valuation analysis, deal process management, and presenting updates to senior leadership. This position serves as the central point for cross-functional due diligence, drafting term sheets, and developing compelling presentations for high-profile biopharma deals. The role requires supervising financial modeling to ensure analytical rigor in transaction decision-making.
Lakefront Biotherapeutics is a clinical-stage biotechnology company developing innovative medicines that transform patient outcomes. Guided by scientific expertise and disciplined capital allocation, the company identifies, accesses, and advances high-quality therapeutic assets in areas of high unmet need. It is listed on both Euronext and NASDAQ (LKFT) and is headquartered in Mechelen, Belgium.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Lakefront Biotherapeutics.